204 related articles for article (PubMed ID: 6990406)
21. [The role of Mycobacterium bovis in epidemiology of tuberculosis].
Krebs A; Käppler W
Z Erkr Atmungsorgane; 1982; 158(1-2):101-9. PubMed ID: 7041439
[TBL] [Abstract][Full Text] [Related]
22. Effect of an immunomodulator containing Mycobacterium w on sputum conversion in pulmonary tuberculosis.
Patel N; Deshpande MM; Shah M
J Indian Med Assoc; 2002 Mar; 100(3):191-3. PubMed ID: 12408283
[TBL] [Abstract][Full Text] [Related]
23. [Treatment of newly detected destructive pulmonary tuberculosis with antibacterial preparations by the maximum concentration limit method].
Ertli AA; Agkatsev TV; Kozhevnikov SF; Albegov EA
Probl Tuberk; 1980 May; (5):46-8. PubMed ID: 7384048
[No Abstract] [Full Text] [Related]
24. [Effectiveness of abbreviated biphasic treatment in pulmonary tuberculosis].
Cramer G
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1981; 30(3):177-80. PubMed ID: 6273990
[No Abstract] [Full Text] [Related]
25. Prevalence of Mycobacterium bovis in human pulmonary and extra-pulmonary tuberculosis in Madagascar.
Rasolofo-Razanamparany V; Ménard D; Rasolonavalona T; Ramarokoto H; Rakotomanana F; Aurégan G; Vincent V; Chanteau S
Int J Tuberc Lung Dis; 1999 Jul; 3(7):632-4. PubMed ID: 10423227
[TBL] [Abstract][Full Text] [Related]
26. Treatment of Mycobacterium bovis infected tuberculosis patients: San Diego County, California, United States, 1994-2003.
LoBue PA; Moser KS
Int J Tuberc Lung Dis; 2005 Mar; 9(3):333-8. PubMed ID: 15786900
[TBL] [Abstract][Full Text] [Related]
27. The etiologic role of M. bovis in the pulmonary and urogenital tuberculosis.
Blagodarny YA; Sidorkina EB; Krivtsova AE
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1980; 29(4):245-9. PubMed ID: 6270777
[No Abstract] [Full Text] [Related]
28. [Early and late results of 6-month treatment of pulmonary tuberculosis with various drug combinations].
Rogowski J; Zierski M; Bek E; Snider DE; Long MW
Pneumonol Pol; 1982 Sep; 50(9):425-35. PubMed ID: 7163000
[No Abstract] [Full Text] [Related]
29. [Treatment effectiveness in newly detected destructive pulmonary tuberculosis using different combinations of chemical preparations].
Pospelov VV; Pashkov IuN
Probl Tuberk; 1982 Mar; (3):38-40. PubMed ID: 7088921
[No Abstract] [Full Text] [Related]
30. [Long-term results of treatment for drug-resistant pulmonary tuberculosis in socially adapted patients].
Khodashova ML; Iuditskiĭ MV; Semenova OV
Probl Tuberk Bolezn Legk; 2004; (3):26-8. PubMed ID: 15338896
[TBL] [Abstract][Full Text] [Related]
31. [Effectiveness of tuberculin and chemotherapy in destructive forms of pulmonary tuberculosis].
Stamboltsian EP; Saakian AL; Oganesian LO; Megrabian SA; Apresian EA
Probl Tuberk; 1981 Apr; (4):69-70. PubMed ID: 7255378
[No Abstract] [Full Text] [Related]
32. [Results of intravenous chemotherapy in destructive pulmonary tuberculosis patients].
Ursov IG; Borovinskaia TA
Vrach Delo; 1981 Feb; (2):74-7. PubMed ID: 7222618
[No Abstract] [Full Text] [Related]
33. [Effectiveness of short-term chemotherapy in patients with newly detected destructive pulmonary tuberculosis].
Gol'dshtein VD; Komissarenko IB; Churilova RI; Kulik EI; Niamtsu EA
Probl Tuberk; 1984 Jan; (1):29-34. PubMed ID: 6701168
[No Abstract] [Full Text] [Related]
34. [Comparative evaluation of tuberculosis therapy regimens in treating patients with destructive pulmonary tuberculosis].
Berezovskiĭ BA; Marchak VV; Shepetovskaia TA; Zaĭkov SV; Nagornaia EG
Probl Tuberk; 1985; (10):28-30. PubMed ID: 4070200
[No Abstract] [Full Text] [Related]
35. [Comparative characteristics of disseminated pulmonary tuberculosis in patients isolating Mycobacterium tuberculosis with a high and low viability].
Koretskaia NM; Iarygina IV
Probl Tuberk Bolezn Legk; 2007; (2):17-20. PubMed ID: 17419328
[TBL] [Abstract][Full Text] [Related]
36. [Intermittent therapy of chronic destructive forms of pulmonary tuberculosis].
Derkach VS; Protsiuk RG; Chernyshev VM
Vrach Delo; 1980 Aug; (8):42-4. PubMed ID: 7415126
[No Abstract] [Full Text] [Related]
37. [Chemotherapy effectiveness in chronic and hyperchronic forms of destructive pulmonary tuberculosis].
Kartoziia LS
Probl Tuberk; 1981 Apr; (4):32-5. PubMed ID: 7255373
[No Abstract] [Full Text] [Related]
38. [Blood coagulation state in destructive pulmonary tuberculosis patients under different methods of chemotherapy].
Sagalovich VIa; Beresneva RE; Ivanova VB
Probl Tuberk; 1981 May; (5):30-4. PubMed ID: 7255385
[No Abstract] [Full Text] [Related]
39. [Tuberculosis caused by Mycobacterium bovis: apropos of 2 cases].
Aguirre Errasti JM; Povar Marco J; Arazo Garces P; Ramos Paesa C; Lezcano Carreras MA; Nabal Vicuña M; Sánchez-Celaya del Pozo C
An Med Interna; 1992 May; 9(5):239-40. PubMed ID: 1504206
[TBL] [Abstract][Full Text] [Related]
40. [Possibilities of reducing the hospital-stage chemotherapy of patients with fibro-cavernous pulmonary tuberculosis].
Naubet'iarova AN; Alibekova MKh
Probl Tuberk; 1985; (3):38-40. PubMed ID: 4011589
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
